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ABSTRACT
Background: Surgical treatment for inferior turbinate (IT) is selected to treat severe allergic rhinitis (AR) that
is unresponsive to conservative treatment. This study aimed to determine the clinical effects of outpatient sub-
mucosal IT surgery (OSITS) on patients with severe AR.
Methods: Between January 2008 and August 2012, 95 patients with severe AR who underwent OSITS at the
Department of Otolaryngology, Hyogo College of Medicine, were retrospectively analyzed. There were 53 men
and 42 women. Their mean age was 27 years (11-75 years). OSITS was bilaterally performed using a bipolar
radiofrequency electrocautery under local anesthesia. Symptoms, QOL, and physical findings were evaluated
using scores from both pre- and postoperative periods (average: 12.4 months), according to Practical Guideline
for the Management of AR in Japan 2009.
Results: In perennial AR, all mean scores of nasal symptoms, QOL, and physical findings significantly im-
proved after OSITS (p < 0.05, n = 83). Nasal obstruction, sleep problems, and IT congestion were the most
strongly affected. Eye symptoms were not influenced by OSITS. OSITS also showed significant effects on na-
sal obstruction and IT congestion in seasonal AR (p < 0.05, n = 12), but not sneezing, nasal discharge, and
QOL. In terms of the efficacy, OSITS was beneficial in 90% of perennial AR cases and 75% of seasonal AR
cases. Epistaxis (1%), vestibulitis (1%), and IT atrophy (4%) were observed after OSITS.
Conclusions: These data indicate that OSITS using radiofrequency electrocautery could be a beneficial
therapeutic option in patients with severe AR.
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INTRODUCTION
The incidence of allergic rhinitis (AR) has been in-
creasing and it is now considered a national disease
in Japan. The main clinical symptoms of AR are
sneezing, serous nasal discharge, andor nasal ob-
struction. Severe nasal symptoms can reduce the per-
formance and productivity of individuals, as well as
their quality of life (QOL).
For the treatment of AR, pharmacotherapy is in-
itially selected, together with communication with pa-
tients about the avoidance of antigens.1 When pa-
tients with severe AR do not show any responses to
medication, surgical treatment is recommended to re-
lieve their symptoms. Inferior turbinate surgery (ITS)
is one of the procedures for severe AR. There are
various methods of ITS for mucosal and submucosal
tissues.2,3 For mucosal ITS, cautery has been per-
formed with various devices, such as radiofrequency
electrocoagulation surgery,4-9 argon plasma coagula-
tion,10 CO2 laser,11,12 yttrium-aluminum-garnet (YAG)
laser,13,14 and chemosurgery (80% trichloroacetic
acid).15 For submucosal ITS, radiofrequency cautery,
resection with a micro-debrider, and IT bone resec-
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tion have been performed.2,3 However, it is still con-
troversial whether or not outpatient submucosal ITS
(OSITS) using radiofrequency electrocautery has sig-
nificant effects on severe AR.
The purpose of this study was to investigate in de-
tail the change of main symptoms, QOL, and intrana-
sal findings after OSITS, and to evaluate the effects of
OSITS on perennial and seasonal AR.
METHODS
PATIENTS AND DIAGNOSIS
Among patients seen between January 2008 and Au-
gust 2012, 95 patients with severe AR who underwent
bilateral OSITS at the Department of Otolaryngology,
Hyogo College of Medicine, were retrospectively ana-
lyzed for both pre- and postoperative nasal condi-
tions. OSITS was performed on all patients after the
provision of informed consent. This study conformed
to the regulations of the ethics committee of Hyogo
College of Medicine (approval number: 1512). There
were 53 men and 42 women. Their mean age was 27
years, ranging from 11 to 75 years. Asthma was an ac-
companying condition in 25 patients (26.3%), while
atopic dermatitis was also present in 16 patients
(16.8%). Patients who were not seen postoperatively
were excluded from this study. Patients with any na-
sal polyps and sinusitis were also excluded.
AR was diagnosed on the basis of a detailed clinical
history, three nasal symptoms (sneezing, watery rhi-
norrhea, and nasal obstruction), intranasal findings,
and the identified causative allergen, according to the
Practical Guideline for the Management of Allergic
Rhinitis in Japan 2009 (referred to as the guidelines
hereafter).1 Radioimmunosorbent testing for non-
specific (RIST) and specific (RAST) immunoglobulin
E (IgE) antibodies was also undertaken to investigate
the presence or absence of atopic disposition. Total
serum IgE and specific IgE titers (house dust, mites,
cedar, cypress, orchard grass, ragweed and mug-
wort) were measured by fluorescent enzyme immu-
noassay (CAP-FEIA, Phadia K.K., Tokyo, Japan). Hy-
perglobulinemia of IgE (173 Uml < RIST) was found
in 49 patients (51.6%). Specific IgE classes two and
over were considered to indicate positive to the aller-
gens. In total, 39 patients (24 men and 15 women, av-
erage age 27.3 years) had perennial AR alone, 12 pa-
tients (6 men and 6 women, 25.8 years) had seasonal
AR alone, and the remaining 44 patients (23 men and
21 women, 28.6 years) had both perennial and sea-
sonal AR (combined AR).
The condition in perennial AR was evaluated in the
pre- (n = 83) and three postoperative periods. The
condition in combined AR was evaluated at a time
when pollen antigens were not present in the air, and
was included in the category of perennial AR. The
first period was between 3 and 6 months (n = 75, av-
erage 4.5 months), the second period was between 7
and 12 months (n = 44, average 11.7 months), and the
third period was between 13 and 24 months (n = 22,
average 21.9 months) after the OSITS. Patients with
seasonal AR were evaluated on an annual seasonal ba-
sis, when pollen allergens were present in the air (n =
12).
SURGICAL PROCEDURES OF OSITS
OSITS was bilaterally performed with 0 degree endo-
scopy under local anesthesia in an outpatient setting.
CelonLab ENTⓇ (Celon, Olympus, Tokyo, Japan), a
bipolar radiofrequency-induced thermotherapy appli-
cator designed for reduction of the submucosal IT
volume, was used. No premedication was given. Be-
fore OSITS, bilateral nasal cavity was anesthetized by
inserting cotton pledgets that had been immersed in
4% lidocaine hydrochloride and 0.02% epinephrine.
The pledgets were placed along the IT for 30-40 min-
utes. A dose of 1-2 ml of 1% lidocaine hydrochloride
and 0.001% epinephrine (AstraZeneca K.K., Osaka, Ja-
pan) was additionally injected into the submucosa of
IT on each side. The submucosal layer of IT was cau-
terized at an output of 20 W. The operation took
about 5 minutes on both sides. If no bleeding was ob-
served 30 min later, the patients left hospital without
bandaging.
EVALUATION OF THE CHANGES IN SYMPTOMS
AND INTRANASAL FINDINGS
The Japanese Allergic Rhinitis QOL Standard Ques-
tionnaire (JRQLQ No. 1), according to the Japanese
guidelines, was used for evaluation.16 The JRQLQ is
composed of three parts (I-III): (I) nasal and eye
symptoms; (II) a QOL-related questionnaire; and (III)
an overall face scale. Differences in the JRQLQ (I-III)
scores between before and after OSITS were ana-
lyzed in this study. For JRQLQ I, the nasal and eye
symptoms included the six categories of runny nose,
sneezing, blocked nose, itchy nose, itchy eyes, and
watery eyes. Patients evaluated symptoms on a five-
point scale: 0 for no symptoms, 1 for mild, 2 for mod-
erately severe, 3 for severe, and 4 for very severe
symptoms. For JRQLQ II, the QOL-related question-
naire included six domains [A-F] that consisted of 17
items (i-xvii): [A] ‘usual daily activities’ with five
items of (i) reduced productivity at workhome
school, (ii) poor mental concentration, (iii) reduced
thinking power, (iv) impaired reading of booksnews-
papers, and (v) reduced memory; [B] ‘outdoor activi-
ties’ with two items of (vi) limitation of outdoor life
(e.g. sports, picnic) and (vii) limitation of going out;
[C] ‘social functioning’ with three items of (viii) hesi-
tation visiting friend or relatives, (ix) reduced contact
with friends or others by telephone or face-to-face
conversation, and (x) not an easy person to be
around; [D] ‘sleep problems’ with one item of (xi) im-
paired sleeping; [E] ‘general physical problems’ with
two items of (xii) tiredness and (xiii) fatigue; and [F]
‘emotional function’ with four items of (xiv) frustra-
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tion, (xv) irritability, (xvi) depression, and (xvii) un-
happiness. Each item was evaluated on a five-point
scale: 0 for no significant problem, 1 for mild, 2 for
moderately severe, 3 for severe, and 4 for a very se-
vere problem. The mean score of each domain was
calculated for analysis. For JRQLQ III, an overall face
scale, including overall symptoms, condition, and
feelings, was evaluated on a five-point scale from 0 for
‘happy’ to 4 for ‘crying’.
Efficacy of OSITS was defined as a change in sever-
ity in terms of the degree of three nasal symptom
scores.1 Severity was defined using a five-point scale
(0 for no symptoms, 1 for mild, 2 for moderate, 3 for
severe, 4 for most severe) by a combination of
blocked nose and a higher score of sneezing and na-
sal discharge. Efficacy was determined when there
was a difference in the severity between before and
after OSITS. When the severity score decreased, we
considered it to reflect an improvement. The efficacy
rate, which indicates the percentage of total patients
showing an improvement, was calculated.
We retrospectively investigated what kinds of
medicine were prescribed for all patients enrolled in
this study using our clinical records. On the basis of
the guideline1 and a previous study,17 each medicine
that patients were taking at the time of examination
was scored. The score was 1 point for the use of oral
antihistamine or leukotriene receptor antagonist,
vasoconstrictors in nasal drops, or antihistamine and
releasers in eye-drops. The score was 2 points for the
use of corticosteroids in nasal sprays, or corticoster-
oid eye-drops. The use of betamethasone and d-
chlorpheniramine maleate was scored as 2.5 points. If
patients used more than one medicine, the total score
was calculated. The usual daily dose before OSITS
was considered as the standard. Differences from the
preoperative standard after OSITS were analyzed.
We also applied a visual analog scale (VAS) to
measure the patients’ satisfaction with nasal symp-
toms before and after OSITS. VAS consisted of a 10
cm linear scale; the opposing ends of the scale indi-
cated minimal (0%) and maximal levels of satisfaction
with nasal symptoms (100%). The distance to the
point that patients checked on the line was measured
in millimeters. The value was then represented as the
nasal VAS score (%).
Intranasal findings were evaluated before and after
OSITS based on the guideline.18 The degree of IT
congestion of the mucosa was scored on a four-point
scale: 0 for no swelling; 1 for over half of the middle
turbinate (MT) being visible; 2 for intermediate be-
tween points 1 and 3; and 3 for the MT not being vis-
ible.18,19 The amount of nasal discharge was scored
on a four-point scale: 0 for no nasal discharge; 1 for a
small amount of nasal discharge; 2 for intermediate
between points 1 and 3; and 3 for nasal discharge fill-
ing the nasal cavity.
Nasal resistance was measured using rhinoma-
nometry by an anterior method (multi-functional spi-
rometer HI-801, Chest, Tokyo, Japan) before and af-
ter OSITS. A resistance value of 100 Pa (Pacm3s)
between pressure and nasal airflow for resting respi-
ration was adopted.
Wilcoxon signed-rank test was used for statistical
analysis using the software StatView (version 5.0).
Differences were considered significant if the p value
was less than 0.05. Data are presented as mean ±
standard error (S.E.).
RESULTS
PERENNIAL AR
Changes in Symptoms after OSITS
On average, all nasal symptom scores in JRQLQ I sig-
nificantly improved and were maintained up to the
third period after OSITS (Table 1). The preoperative
runny nose score significantly improved. Improve-
ment of sneezing score also showed significance,
similar to that of runny nose. Blocked nose score was
the severest of the preoperative nasal symptoms. The
mean score of blocked nose strongly improved. Im-
provement of the score of itchy nose also showed sig-
nificance. The rate of improvement of blocked nose
was the best among the nasal symptoms. Taken to-
gether, the efficacy rates in the first, second, and
third periods after OSITS were 90.7%, 88.6%, and
90.9%, respectively. Mean preoperative nasal VAS
score of 25.3 ± 2.0% significantly improved to 63.3 ±
3.4% (n = 75, p < 0.0001) in the first period, 66.2 ± 3.7%
(n = 44, p < 0.0001) in the second period, and up to
79.0 ± 4.9% (n = 22, p = 0.0002) in the third period.
These data suggest that OSITS using Celon might be
effective for patients with severe perennial AR in or-
der to improve the nasal symptoms. On the other
hand, eye symptom scores for itchy eyes and watery
eyes did not show much improvement. Mean preop-
erative medication score (0.4 ± 0.1, n = 83) did not
show a downward trend in terms of the amount of
medicine: 0.3 ± 0.2 (n = 75, p = 0.6823) in the first, 1.1
± 0.3 (n = 44, p = 0.0717) in the second, and 0.4 ± 0.3
(n = 22, p = 0.7498) in the third period after OSITS.
Changes in QOL after OSITS
Table 2 summarizes pre- and postoperative scores in
JRQLQ II and III. In JRQLQ II, the score of sleep
problems was the severest in the six domains in the
preoperative stage. All six domains significantly im-
proved after OSITS, except for outdoor activities and
social functioning in the second period. For JRQLQ
III, overall face scale showed a significant improve-
ment up to the second period after OSITS.
Changes in Physical Findings after OSITS
Changes in the intranasal findings are shown in Table
3. The mean score of preoperative congestion signifi-
cantly improved after OSITS. Preoperative mean na-
sal resistance value (Pa100) of 0.6 ± 0.3 (Pacm3s)
Kojima Y et al.
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Table　1　Changes in symptom scores after OSITS in perennial AR
Pre 
(n = 83)
1st period 3-6 months 
(n = 75)
2nd period 7-12 months 
(n = 44)
3rd period 13-24 months 
(n = 22)
1. Runny nose 1.8 ± 0.1 1.1 ± 0.1 (<0.0001)** 1.1 ± 0.2 (0.0071)* 0.6 ± 0.1 (0.0007)*
56.0% (42/75) 50.0% (22/44) 68.2% (15/22)
2. Sneezing 1.2 ± 0.1 0.8 ± 0.1 (<0.0001)** 0.8 ± 0.2 (0.0118)* 0.6 ± 0.1 (0.0272)*
40.0% (30/75) 43.2% (19/44) 54.5% (12/22)
3. Blocked nose 2.7 ± 0.1 1.2 ± 0.1 (<0.0001)** 1.2 ± 0.2 (<0.0001)** 0.8 ± 0.2 (0.0001)*
78.7% (59/75) 68.2% (30/44) 81.8% (18/22)
4. Itchy nose 1.1 ± 0.1 0.7 ± 0.1 (0.0002)* 0.5 ± 0.1 (0.01)* 0.5 ± 0.2 (0.0072)*
45.3% (34/75) 45.5% (20/44) 59.1% (13/22)
5. Itchy eyes 1.0 ± 0.1 0.6 ± 0.1 (0.0001)* 0.5 ± 0.1 (0.2267) 0.4 ± 0.1 (0.0622)
38.7% (29/75) 22.7% (10/44) 36.4% (8/22)
6. Watery eyes 0.4 ± 0.1 0.3 ± 0.1 (0.1642) 0.2 ± 0.1 (0.7762) 0 (0.1573)
21.3% (16/75) 13.6% (6/44) 18.2% (4/22)
Efficacy rate 90.7% (68/75) 88.6% (39/44) 90.9% (20/22)
Nasal and eye symptom scores in JRQLQ I in the pre- and 1st, 2nd, and 3rd postoperative periods are shown. Upper lanes show the symp-
tom scores as mean  ±  S.E. (p values), and lower lanes show their improvement rates (number of patients). Asterisks indicate signifi cance 
between before and after OSITS (*p < 0.05, **p < 0.0001).
Table　2　Changes in QOL scores after OSITS in perennial AR
Pre 
(n = 83)
1st period 3-6 months 
(n = 75)
2nd period 7-12 months 
(n = 44)
3rd period 13-24 months
(n = 22)
II 1. Usual daily activities 0.9 ± 0.1 0.3 ± 0.1 (<0.0001)** 0.2 ± 0.1 (0.0007)* 0.2 ± 0.1 (0.0123)*
72.0% (54/75) 54.5% (25/44) 59.1% (13/22)
2. Outdoor activities 0.5 ± 0.1 0.2 ± 0.1 (0.0016)* 0.2 ± 0.1 (0.067) 0 (0.0031)*
34.7% (26/75) 31.8% (14/44) 50.0% (11/22)
3. Social functioning 0.5 ± 0.1 0.2 ± 0.1 (0.0004)* 0.2 ± 0.1 (0.0677) 0.1 ± 0 (0.0172)*
33.3% (25/75) 34.1% (15/44) 45.5% (10/22)
4. Sleep problem 1.3 ± 0.1 0.7 ± 0.1 (0.0003)* 0.5 ± 0.1 (0.0005)* 0 (0.0018)*
53.3% (40/75) 47.7% (21/44) 59.1% (13/22)
5. General physical problems 1.2 ± 0.1 0.5 ± 0.1 (0.0001)* 0.4 ± 0.1 (0.0023)* 0.3 ± 0.1 (0.0212)*
49.3% (37/75) 50.0% (22/44) 50.0% (11/22)
6. Emotional function 0.7 ± 0.1 0.4 ± 0.1 (0.0009)* 0.2 ± 0.1 (0.0009)* 0 (0.0007)*
52.0% (39/75) 50.0% (22/44) 68.2% (15/22)
III Overall face scale 2.3 ± 0.1 1.7 ± 0.1 (0.0001)* 1.8 ± 0.2 (0.021)* 2.0 ± 0.2 (0.4962)
58.7% (44/75) 50.0% (22/44) 36.4% (8/22)
Upper lanes show the scores as mean ± S.E. (*p < 0.05; **p < 0.0001), and lower lanes show their improvement rates (number of pa-
tients).
significantly improved to 0.3 ± 0.1 (Pacm3s) at an
average of 4.5 months (3-9 months) in eight patients
who we could examine before and after OSITS (p =
0.0431). The mean scores of the amount of nasal dis-
charge also significantly decreased. The rates of im-
provement in IT congestion were better than those
for the amount of discharge.
SEASONAL AR
The mean blocked nose score in JRQLQ I signifi-
cantly improved, whereas those of runny nose and
sneezing did not show significance at 12 months after
OSITS (Table 4). Efficacy in terms of the nasal symp-
tom scores was found at a rate of 75.0%. Mean nasal
VAS score also improved from 11.1 ± 2.0% to 50.9 ±
9.7% at 12 months after OSITS (p = 0.0029). Mean
score of IT congestion significantly improved after
OSITS, whereas the amount of nasal discharge did
not. In total, 83% showed improvement of blocked
nose and IT congestion. Meanwhile, there were no
significant differences before and after OSITS in
JRQLQ I in terms of eye symptoms, between II and
III. Sleep problems, which showed a downward trend
from 1.8 ± 0.4 to 0.7 ± 0.4 (p = 0.0725), were the most
OSITS for Severe AR
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Table　3　Changes in intranasal fi ndings after OSITS in perennial AR
Pre 
(n = 83)
1st period 3-6 months 
(n = 75)
2nd period 7-12 months 
(n = 44)
3rd period 13-24 months 
(n = 22)
Congestion of IT 2.3 ± 0.1 0.6 ± 0.1 (<0.0001)** 0.7 ± 0.1 (<0.0001)** 0.8 ± 0.2 (<0.0001)**
92.0% (69/75) 86.4% (38/44) 95.5% (21/22)
Amount of discharge 1.2 ± 0.1 0.5 ± 0.1 (<0.0001)** 0.4 ± 0.1 (<0.0001)** 0.3 ± 0.1 (0.0012)*
54.7% (41/75) 63.6% (28/44) 63.6% (14/22)
Scores of mean ± S.E. (*p < 0.05; **p < 0.0001) and improvement rates (number of patients) are shown in upper and lower lanes, respec-
tively.
Table　4　Changes in symptoms and physical fi ndings in 
seasonal AR
Pre 
(n = 12)
12 months after 
OSITS
1. Runny nose 1.8 ± 0.4 1.8 ± 0.4 (0.7302)
25.0% (3/12)
2. Sneezing 1.6 ± 0.4 1.6 ± 0.3 (>0.9999)
25.0% (3/12)
3. Blocked nose 3.3 ± 0.3 1.6 ± 0.5 (0.0223)*
83.3% (10/12)
4. Itchy nose 1.2 ± 0.3 0.6 ± 0.1 (0.0845)
41.7% (5/12)
5. Itchy eyes 1.3 ± 0.3 1.4 ± 0.4 (0.6029)
25.0% (3/12)
6. Watery eyes 0.4 ± 0.2 0.4 ± 0.3 (>0.9999)
16.7% (2/12)
Efficacy rate 75% (9/12)
Congestion of IT 2.4 ± 0.2 0.5 ± 0.2 (0.0041)*
83.3% (10/12)
Amount of discharge 1.1 ± 0.3 0.7 ± 0.2 (0.1597)
41.7% (5/12)
Upper and lower lanes show the symptom scores as mean ±
S.E. (p values) and the improvement rates (number of patients), 
respectively. Asterisks indicate signifi cance between before and
after OSITS (n = 12, *p < 0.05).
affected among the six domains of JRQLQ II, with im-
provement found in 66.7% of patients (812). The
mean preoperative medication score of 0.9 ± 0.3
changed to 1.4 ± 0.6 after OSITS, but this was not sig-
nificant (n = 12, p = 0.2142).
POSTOPERATIVE COMPLICATIONS AFTER OS-
ITS
No patients suffered from postoperative pain. In
terms of early complications, all patients had nasal
obstruction due to fibrin coagulation for at least 7-14
days after OSITS. Significant nasal bleeding, for
which a doctor had to be consulted, was found in 1.1%
of patients (195) (Fig. 1). This patient was a 48-year-
old woman with right nasal bleeding from the exter-
nal side of IT who visited our outcome office by am-
bulance after consultation for an hour one month af-
ter OSITS (Fig. 1A). Severe infectious nasal vestibuli-
tis, for which intravenous administration of antibiotics
was required, was also found in one patient (1.1%) 7
days after OSITS. The late complication of atrophic
change of IT was observed in 4.2% (495) (Fig. 1B).
The age distribution of these four patients was from
21 to 48 years. Four patients underwent OSITS again,
after a mean interval of 27 months (12-46 months).
The mean age of these patients was 23.8 years (14-49
years), and three of them were teenagers.
DISCUSSION
This study demonstrated that OSITS using radiofre-
quency electrocautery had beneficial effects in ap-
proximately 90% of patients with perennial AR and
75% of those with seasonal AR. Nasal obstruction,
sleep problems, and IT congestion were the most
strongly affected with regard to the symptoms, QOL,
and physical findings, respectively, in both perennial
and seasonal AR.
OSITS is intended to reduce interstitial edema
causing small nasal airways in submucosal IT tissues
and to induce interstitial fibrosis to improve severe
nasal symptoms. A significant reduction of IT volume
led to the improvement of nasal obstruction. The con-
sequence of better nasal respiration was suggested to
be a positive effect on sleep.20 Both afferent and effer-
ent fibers in the submucosa are also thought to be
heat-denatured by OSITS. Sneezing and nasal dis-
charge certainly improved, although the levels of effi-
cacy for these variables were not as good as that for
nasal obstruction. The data of nasal symptom scores
were confirmed by intranasal findings.
Seeger J et al. reported the improvement of nasal
breathing in 85% at 20 months after radiofrequency-
induced thermotherapy.4 Nease CJ et al. reported
that the severity of nasal obstruction improved in
47.5% at 8 weeks after radiofrequency volumetric tis-
sue reduction.5 Garzaro M et al. reported that Nasal
Obstruction Symptom Evaluation test score improved
in 100% at 2 months and at 2 years after radiofre-
quency inferior turbinate reduction.7 According to
our previous study on outpatient mucosal ITS using
argon plasma coagulation, sneezing, nasal discharge,
and nasal obstruction improved in 75%, 60%, and 75%
of patients with perennial AR in the first postoperative
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Fig.　1　Complicated changes of IT after OSITS. A 48-year-old woman. IT mucosa was necrotic 
and the bone was exposed (arrow) the second month after OSITS (A). IT became atrophic (ar-
rowhead) the sixth month after OSITS (B). S, septum; IT, inferior turbinate; MT, middle turbinate.
IT
S
Right
IT
S
MT
Right
A B
year (n = 95), respectively.10 In this study, sneezing,
nasal discharge, and nasal obstruction improved in
43%, 50%, and 68% in the second period after OSITS
using Celon (n = 44), respectively. The scores in this
study indicated a worse rate of failure than with mu-
cosal ITS. Meanwhile, OSITS caused more improve-
ment of IT congestion in this study (86%) than in mu-
cosal ITS (64%).10
Considering the patients’ QOL, all domains of
JRQLQ II significantly improved after OSITS in per-
ennial AR, but not in seasonal AR. Most patients with
perennial AR might have felt better than before if
their baseline level became only slightly better. In
contrast, patients with seasonal AR might hope to be-
come completely asymptomatic after OSITS, even in
the presence of pollen.
OSITS using radiofrequency electrocautery, as a
form of outpatient surgery, can be performed even for
pediatric patients if they can sit quietly without mov-
ing during surgery. An eleven-year-old boy was the
youngest patient in this study. Patients had no post-
operative limitations in daily life. No significant com-
plications of radiofrequency ITS were reported in
some previous studies.5,7 In this study, however, we
experienced nasal bleeding in 1%, as in a previous re-
port (0.7%),21 severe nasal vestibulitis in 1%, and IT at-
rophy in 4%. The nasal vestibulitis was thought to
have been caused by a heat-induced change or bacte-
rial infection. Radiofrequency ITS cauterized the sub-
mucosal layer of IT, so we could not see the change
in the submucosal tissue under direct vision. The IT
atrophy was thought to have been caused by too
much cauterization. Complication of IT atrophy was
seen for the first 13 months only at our department.
Two sessions of OSITS were required in 4% because
the nasal symptoms, particularly nasal obstruction,
remained or relapsed. A tendency for younger pa-
tients to show less of an effect was also observed.
We actually performed OSITS on 436 patients with
severe AR in the period focused on in this study.
However, we could not follow up all of the patients,
despite recommending regular postoperative obser-
vation. AR is not a life-threatening disease. As such,
there might have been some patients who did not
visit us when their symptoms disappeared com-
pletely, andor who visited us only when their symp-
toms became severer. Therefore, statistically accu-
rate evaluation of the longer-term therapeutic effect
was difficult. These might be the reasons why our re-
sults were worse than those in previous studies.4,10
Although OSITS is available for severe AR, its com-
bination with surgery requiring hospitalization (such
as septoplasty, turbinectomy, and neurotomy) is still
required in patients with no beneficial effects after
OSITS. Allergy cannot be completely cured by surgi-
cal treatments alone. Therefore, an effective therapy
that can replace surgery is anticipated.
It is concluded that minimal surgery, namely, OS-
ITS using radiofrequency electrocautery, had a bene-
ficial effect in more than 75% of patients with severe
AR. Patients suffering from nasal obstruction, rather
than those with sneezing and nasal discharge, were
satisfied with the results of OSITS.
REFERENCES
1. Okubo K, Kurono Y, Fujieda S et al. Japanese guideline
for allergic rhinitis. Allergol Int 2011;60:171-89.
2. Passali D, Lauriello M, Anselmi M, Bellussi L. Treatment
of hypertrophy of the inferior turbinate: long-term results
in 382 patients randomly assigned to therapy. Ann Otol
Rhinol Laryngol 1999;108:569-75.
3. Rakover Y, Rosen G. A comparison of partial inferior tur-
binectomy and cryosurgery for hypertrophic inferior tur-
binates. J Laryngol Otol 1996;110:732-5.
4. Seeger J, Zenev E, Gundlach P, Stein T, Muller G. Bipolar
radiofrequency-induced thermotherapy of turbinate hy-
pertrophy: pilot study and 20 months’ follow-up. Laryngo-
scope 2003;113:130-5.
5. Nease CJ, Krempl GA. Radiofrequency treatment of tur-
OSITS for Severe AR
Allergology International Vol 62, No4, 2013 www.jsaweb.jp 485
binate hypertrophy: a randomized, blinded, placebo-
controlled clinical trial. Otolaryngol Head Neck Surg 2004;
130:291-9.
6. Cavaliere M, Mottola G, Iemma M. Monopolar and bipo-
lar radiofrequency thermal ablation of inferior turbinates:
20-month follow-up. Otolaryngol Head Neck Surg 2007;
137:256-63.
7. Garzaro M, Pezzoli M, Landolfo V, Defilippi S, Giordano
C, Pecorari G. Radiofrequency inferior turbinate reduc-
tion: long-term olfactory and functional outcomes. Oto-
laryngol Head Neck Surg 2012;146:146-50.
8. Garzaro M, Pezzoli M, Pecorari G, Landolfo V, Defilippi S,
Giordano C. Radiofrequency inferior turbinate reduction:
an evaluation of olfactory and respiratory function. Oto-
laryngol Head Neck Surg 2010;143:348-52.
9. Bäck LJ, Hytönen ML, Malmberg HO, Ylikoski JS. Sub-
mucosal bipolar radiofrequency thermal ablation of infe-
rior turbinates: a long-term follow-up with subjective and
objective assessment. Laryngoscope 2002;112:1806-12.
10. Fukazawa K, Ogasawara H, Tomofuji S, Fujii M, Saka-
gami M. Argon plasma surgery for the inferior turbinate
of patients with perennial nasal allergy. Laryngoscope
2001;111:147-52.
11. DeRowe A, Landsberg R, Leonov Y, Katzir A, Ophir D.
Subjective comparison of Nd: YAG, diode, and CO2 lasers
for endoscopically guided inferior turbinate reduction sur-
gery. Am J Rhinol 1998;12:209-12.
12. Elway S, Abdel-Moneim MH. Carbon dioxide laser tur-
binectomy. An electron microscopic study. J Laryngol Otol
1997;111:931-4.
13. Lippert BM, Werner JA. Comparison of carbon dioxide
and neodymium: yttrium-aluminum-garnet lasers in sur-
gery of the inferior turbinate. Ann Otol Rhinol Laryngol
1997;106:1036-42.
14. Serrano E, Percodani J, Yardeni E, Lombard L, Laffitte F,
Pessey JJ. The holmium: YAG laser for treatment of infe-
rior turbinate hypertrophy. Rhinology 1998;36:77-80.
15. Yao K, Shitara T, Takahashi H, Nishiyama K, Iguchi Y,
Yamamoto K. Chemosurgery with trichloroacetic acid for
allergic rhinitis. Am J Rhinol 1995;9:163-8.
16. Okubo K, Gotoh M, Shimada K, Ritsu M, Kobayashi M,
Okuda M. Effect of fexofenadine on the quality of life of
Japanese cedar pollinosis patients. Allergol Int 2004;53:
245-54.
17. Fujieda S, Kurono Y, Okubo K et al. Examination, diagno-
sis and classification for Japanese allergic rhinitis: Japa-
nese guideline. Auris Nasus Larynx 2012;39:553-6.
18. Baba K, Konno A, Takenaka H et al (eds). [Practical
Guideline for the Management of Allergic Rhinitis in Ja-
pan], 6th edn. Tokyo: Life Science, 2009;2-5 (in Japa-
nese).
19. Iwasaki A, Tokano H, Kamiyama R, Suzuki Y, Kitamura
K. A 24-month-follow-up study of argon plasma coagula-
tion of the inferior turbinate in patients with perennial na-
sal allergy. J Med Dent Sci 2010;57:11-5.
20. Li HY, Lee LA, Wang PC, Chen NH, Lin Y, Fang TJ. Nasal
surgery for snoring in patients with obstructive sleep ap-
nea. Laryngoscope 2008;118:354-9.
21. Bäck LJ, Liukko T, Sinkkonen ST, Ylikoski J, Mäkitie AA.
Complication rates of radiofrequency surgery in the up-
per airways: a single institution experience. Acta Otolaryn-
gol 2009;129:1469-73.
